Press Release Distribution

Members Login  |  Register  |  Why Join?   Follow us on Google+Follow us on TwitterFind us on LinkedInFind Us on FacebookSubscribe to our RSS FeedsSubscribe to our YouTube ChannelFind us on RebelMouse

Video Releases    |    Pricing & Distribution Plans    |    Today's News    |    News By Category    |    News By Date    |    Business Directory
All Press Releases for December 12, 2013 »
RSS Feeds RSS Feed     Print this news Printer Friendly     Email this news Email It    Create PDF PDF Version   

Harald Petry to Speak at Cell & Gene Therapy Feb 20-21, 2014 in San Diego, CA

Harald Petry, uniQure, to Speak at Cell & Gene Therapy Conference Feb 20-21, 2014 in San Diego, CA
x-small text small text medium text large text

    SAN DIEGO, CA, December 12, 2013 /24-7PressRelease/ -- Harald Petry, Chief Scientific Officer of uniQure B.V., will give a featured presentation on evolving regulatory challenges and requirements for drug development at the Inaugural Cell and Gene Therapy Conference on February 20-21, 2014 in San Diego, CA by GTC.

uniQure's Glybera is the first gene therapy approved by the European Commission and by regulatory authorities in the Western world. It is the first medication approved for patients with Lipoprotein Lipase Deficiency, a rare metabolic disorder.

Dr. Petry joined uniQure's predecessor company AMT in May 2007 as Director of Research and Development. He has worked in the area of gene therapy for more than 15 years and has extensive experience in pharmaceutical research. After his PhD, he built up a career in academic research and subsequently in the international biopharmaceutical industry. Prior to joining uniQure, he worked at Jenapharm GmbH (Germany), and Berlex Biosciences (US) in different functions with increasing managerial and leadership responsibility.

Treatment of disease using cell and gene therapy is now a reality. With emerging technologies and new clinical trials being developed and launched at a growing rate, it is important to stay up-to-date with the evolving regulatory challenges and pre-clinical requirements for drug development and discovery. This meeting brings together experts from industry and academia to discuss the development and applications of cell and gene therapy as well as strategies and challenges for commercialization.

This conference is also part of the Future Biotech Summit 2014, which consists of this conference, and two other additional co-located conferences:
Cell & Gene Therapy
2nd Orphan Drugs Research & Commercialization
Ubiquitin Research & Drug Discovery

For more information, please visit

GTC organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic institutions, government organizations and the financial community.

GTC (Global Technology Community), LLC, is a privately held company founded in 2002.

Press release service and press release distribution provided by

# # #

Read more Press Releases from Kristen Starkey:

Contact Information:
Kristen Starkey

Monrovia, CA
United States
Voice: 626-256-6405
E-Mail: Email us Here
Website: Visit Our Website
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7PressRelease. We are unable to assist you with any information regarding this release. 24-7PressRelease disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.